Anidulafungin-Induced Alopecia: A Case Report

In 2014, a case was reported involving a 34-year-old woman who developed alopecia after being treated with anidulafungin for chronic femoral osteomyelitis. Despite multiple surgeries and various treatments, it was only after one month of anidulafungin use that she began to experience significant hair loss, leading to the cessation of the drug after three months due to the development of alopecia plaques. Her condition improved upon switching to micafungin, another antifungal, but a slight reactivation of hair loss was noted when anidulafungin was reintroduced. The Naranjo probability scale suggested a probable link between anidulafungin and alopecia, indicating that physicians should monitor for this side effect to ensure patient adherence to treatment.